Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250354
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-11-04
Brief Title:
A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild Moderate or Borderline Mental Retardation
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Disruptive Behavior Disorder |
| Conduct Disorder |
| Oppositional Defiant Disorder |